$0.284200
-0.0086-2.94%
Pre-Market: 4:07 AM EDT
15 minutes delayed
Comments
Loading...
Qualigen Therapeutics
QLGNNASDAQ
Qualigen Therapeutics (NASDAQ:QLGN) Stock, Earnings Estimates, EPS, And Revenue
Qualigen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 2
EPS
$-0.350
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Qualigen Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| QLGN | Qualigen Therapeutics | -$0.69 | — | — | — | $1.63M | — | — | — | 08/13/2024 | Get Alert |
| QLGN | Qualigen Therapeutics | -$0.78 | — | -$0.35 | — | $1.61M | — | $0.00 | — | 07/02/2024 | Get Alert |
| QLGN | Qualigen Therapeutics | -$1.55 | -$0.52 | -$0.47 | 9.62% | $1.39M | — | $0.00 | — | 04/08/2024 | Get Alert |
| QLGN | Qualigen Therapeutics | -$1.00 | -$0.92 | -$0.64 | 30.43% | $1.44M | $500.00K | $0.00 | -100.00% | 11/14/2023 | Get Alert |
| QLGN | Qualigen Therapeutics | -$1.10 | -$0.52 | -$0.69 | -32.69% | $1.43M | $1.60M | $1.63M | 1.69% | 08/15/2023 | Get Alert |
| QLGN | Qualigen Therapeutics | -$1.20 | — | -$0.78 | — | $722.03K | $2.00M | $1.61M | -19.64% | 05/16/2023 | Get Alert |
| QLGN | Qualigen Therapeutics | -$2.00 | — | -$1.55 | — | $1.48M | — | $1.39M | — | 05/02/2023 | Get Alert |
| QLGN | Qualigen Therapeutics | -$1.00 | -$1.30 | -$1.00 | 23.08% | $1.16M | $1.62M | $1.44M | -11.05% | 11/15/2022 | Get Alert |
| QLGN | Qualigen Therapeutics | -$1.80 | — | -$1.10 | — | $1.12M | — | $1.43M | — | 08/16/2022 | Get Alert |
| QLGN | Qualigen Therapeutics | -$1.30 | — | -$1.20 | — | $1.90M | — | $722.03K | — | 05/13/2022 | Get Alert |
| QLGN | Qualigen Therapeutics | -$31.70 | -$1.70 | -$2.00 | -17.65% | $2.71M | $1.75M | $1.48M | -15.37% | 03/31/2022 | Get Alert |
| QLGN | Qualigen Therapeutics | $4.10 | -$1.90 | -$1.00 | 47.37% | $1.11M | $1.70M | $1.16M | -32.06% | 11/15/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | -$4.10 | -$1.80 | -$1.80 | 0.00% | $837.71K | $1.60M | $1.12M | -30.13% | 08/17/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | -$21.20 | — | -$1.30 | — | $904.07K | — | $1.90M | — | 05/14/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | — | -$1.30 | $4.10 | 415.38% | — | $2.00M | $1.11M | -44.60% | 03/31/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | — | — | -$31.70 | — | — | — | $2.71M | — | 03/31/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | — | — | -$4.10 | — | — | — | $837.71K | — | 11/12/2020 | Get Alert |
| QLGN | Qualigen Therapeutics | — | — | -$21.20 | — | — | — | $904.07K | — | 08/14/2020 | Get Alert |
Qualigen Therapeutics (QLGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-08 | $-0.47 | $-0.52 | 9.62 % |
| Sep 2023 | 2023-11-14 | $-0.64 | $-0.92 | 30.4 % |
| Jun 2023 | 2023-08-15 | $-0.69 | $-0.52 | -32.7 % |
| Sep 2022 | 2022-11-15 | $-1.00 | $-1.30 | 23.1 % |
Qualigen Therapeutics (QLGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2023 | 2023-11-14 | $0 | $500.00K | -100.0 % |
| Jun 2023 | 2023-08-15 | $1.63M | $1.60M | 1.69 % |
| Mar 2023 | 2023-05-16 | $1.61M | $2.00M | -19.6 % |
| Sep 2022 | 2022-11-15 | $1.44M | $1.62M | -11.1 % |
FAQ
When is Qualigen Therapeutics (NASDAQ:QLGN) reporting earnings?
Qualigen Therapeutics (QLGN) is scheduled to report earnings on August 13, 2024. The last reported earnings were for reported on July 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Qualigen Therapeutics (NASDAQ:QLGN)?
The Actual EPS was $-0.35, which missed the estimate of $0.00.
What were Qualigen Therapeutics’s (NASDAQ:QLGN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.